房颤背后的故事——甲亢性心脏病

[1]January CT, Wann LS, Alpert JS, et al. 2014 AHA/ ACC / HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. Circulation,2014,130:e199-e267.
[2]Frost L,Vestergaard P,Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter-A population-based study[ J]. Arch Intern Med,2004,164:1675-1678.
[3]Brent GA. The molecular basis of thyroid hormone action[J]. N Engl J Med. 1994;331(13):847.
[4]Davis PJ, Davis FB. Nongenomic actions of thyroid hormone on the heart. Thyroid. 2002; 12(6): 459.
[5]Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725.
[6]Franchini M, Montagnana M, Manzato F, Vescovi PP. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost 2009;35(3):288-94.
[7]Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke 1988;19(1):15-8.
[8]Sheu JJ, Kang JH, Lin HC, Lin HC. Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study. Stroke 2010;41(5):961-6.
[9]Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977;2(6088): 688-90.
[10]Yuen RW, Gutteridge DH, Thompson PL, Robinson JS. Embolism in thyrotoxic atrial fibrillation. Med J Aust 1979;1(13): 630-1.
[11]Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 1981; 141(9):1191-2.
[12]Traube E, Coplan NL. Embolic risk in atrial fibrillation that arises from hyperthyroidism:review of the medical literature[J]. Tex Heart Inst J,2011,38:225-228.
[13]黄从新,张澍,黄德嘉等. 心房颤动:目前的认识和治疗建议-2015[J]. 中国心脏起搏与心电生理杂志,2015,29(05):377-434.
[14]Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med.2001;344(7):501.